Asthika Goonewardene
Stock Analyst at Truist Financial
(3.84)
# 1,926
Out of 5,023 analysts
321
Total ratings
45.5%
Success rate
5.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Asthika Goonewardene
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVBP ArriVent BioPharma | Reiterated: Buy | $32 → $45 | $28.27 | +59.18% | 6 | Aug 13, 2026 | |
| ACET Adicet Bio | Reiterated: Buy | n/a | $6.50 | - | 14 | Mar 16, 2026 | |
| ALLO Allogene Therapeutics | Reiterated: Buy | $10 | $1.50 | +566.67% | 20 | Mar 13, 2026 | |
| BNTX BioNTech SE | Reiterated: Buy | $155 | $96.90 | +59.96% | 19 | Mar 13, 2026 | |
| LEGN Legend Biotech | Reiterated: Buy | $70 | $18.57 | +276.95% | 10 | Mar 13, 2026 | |
| CRBU Caribou Biosciences | Reiterated: Buy | $7 | $1.22 | +473.77% | 11 | Mar 9, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | n/a | $206.64 | - | 9 | Mar 9, 2026 | |
| CGEN Compugen | Reiterated: Buy | $4 | $2.31 | +73.16% | 20 | Mar 3, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $40 | $25.15 | +59.05% | 4 | Mar 3, 2026 | |
| SEPN Septerna | Reiterated: Buy | n/a | $37.71 | - | 1 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $24.44 | +22.75% | 22 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $34.75 | +38.13% | 40 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $14.22 | - | 28 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $16.76 | +108.89% | 19 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 | $58.39 | -12.66% | 30 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $8 | $1.78 | +349.44% | 25 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.35 | - | 17 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $127 → $145 | $144.74 | +0.18% | 12 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $233.33 | n/a | 1 | Apr 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.23 | n/a | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.60 | n/a | 6 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $15 | $5.09 | n/a | 3 | Aug 23, 2022 |
ArriVent BioPharma
Aug 13, 2026
Reiterated: Buy
Price Target: $32 → $45
Current: $28.27
Upside: +59.18%
Adicet Bio
Mar 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.50
Upside: -
Allogene Therapeutics
Mar 13, 2026
Reiterated: Buy
Price Target: $10
Current: $1.50
Upside: +566.67%
BioNTech SE
Mar 13, 2026
Reiterated: Buy
Price Target: $155
Current: $96.90
Upside: +59.96%
Legend Biotech
Mar 13, 2026
Reiterated: Buy
Price Target: $70
Current: $18.57
Upside: +276.95%
Caribou Biosciences
Mar 9, 2026
Reiterated: Buy
Price Target: $7
Current: $1.22
Upside: +473.77%
Revolution Medicines
Mar 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $206.64
Upside: -
Compugen
Mar 3, 2026
Reiterated: Buy
Price Target: $4
Current: $2.31
Upside: +73.16%
Zymeworks
Mar 3, 2026
Reiterated: Buy
Price Target: $40
Current: $25.15
Upside: +59.05%
Septerna
Mar 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $37.71
Upside: -
Feb 27, 2026
Reiterated: Buy
Price Target: $30
Current: $24.44
Upside: +22.75%
Feb 25, 2026
Reiterated: Buy
Price Target: $48
Current: $34.75
Upside: +38.13%
Feb 25, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.22
Upside: -
Feb 24, 2026
Reiterated: Buy
Price Target: $35
Current: $16.76
Upside: +108.89%
Jan 14, 2026
Reiterated: Buy
Price Target: $51
Current: $58.39
Upside: -12.66%
Jan 13, 2026
Reiterated: Buy
Price Target: $10 → $8
Current: $1.78
Upside: +349.44%
Nov 11, 2025
Reiterated: Buy
Price Target: n/a
Current: $15.35
Upside: -
Nov 3, 2025
Reiterated: Buy
Price Target: $127 → $145
Current: $144.74
Upside: +0.18%
Apr 24, 2024
Reiterated: Hold
Price Target: n/a
Current: $233.33
Upside: n/a
Mar 21, 2024
Rated: Hold
Price Target: n/a
Current: $7.23
Upside: n/a
Jan 16, 2024
Rated: Hold
Price Target: n/a
Current: $1.60
Upside: n/a
Aug 23, 2022
Reiterated: Buy
Price Target: $19 → $15
Current: $5.09
Upside: n/a